Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 8,536 | 2,416 | 328 | 2,918 | 0 |
| Gross Profit | 8,536 | 2,416 | 328 | 2,918 | N/A |
| Operating Expenses | 23,192 | 21,034 | 23,028 | 19,743 | 0 |
| Operating Income | -14,656 | -18,618 | -22,700 | -16,825 | N/A |
| Other Income | -322 | 228 | 898 | 1,308 | 0 |
| Pre-tax Income | -14,978 | -18,390 | -21,802 | -15,517 | 0 |
| Income Tax | 436 | 104 | 293 | 59 | N/A |
| Net Income Continuous | -15,414 | -18,494 | -22,095 | -15,576 | N/A |
| Net Income | $-15,414 | $-18,494 | $-22,095 | $-15,576 | $N/A |
| EPS Basic Total Ops | -0.24 | -0.24 | -0.30 | -0.24 | N/A |
| EPS Basic Continuous Ops | -0.22 | -0.26 | -0.31 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.24 | -0.24 | -0.30 | -0.24 | N/A |
| EPS Diluted Continuous Ops | -0.22 | -0.26 | -0.31 | -0.22 | N/A |
| EBITDA(a) | $-13,782 | $-17,800 | $-21,851 | $-16,080 | $N/A |